United States · Health Care · USD (Millions) · Annual
Key financials
USD|Millions
ROE
66.2%
2025 (actual)
ROA
31.89%
2025 (actual)
Gross Margin
61.8%
2025 (actual)
Net Margin
24.62%
2025 (actual)
Total Assets
$3,350.76M
2025 (actual)
Net Income
$1,059.46M
2025 (actual)
Valuation
$53,297.79M
2026 (forecast)
Stock Price
$676.53
Historical & projected performance
USD|Millions
Reported figures and Equlion model projections for the next 5 years.
ROE
-52.6 pt
Company
Sector average
ROA
-21.3 pt
Company
Gross Margin
-16.4 pt
Company
Sector average
Net Margin
-13.2 pt
Company
Total Assets
+186.8%
Company
Sector average
Net Income
-8.8%
Company
Valuation
+21.8%
Company
Sector average
Stock Price
+21.8%
Company
Sector average (own scale)
Amounts in USD (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for IDEXX LABORATORIES INC /DE? It covers the balance sheet, income statement, cash flow and Equlion model projections.